Computational modeling of cardiac fibroblasts and fibrosis

Journal of Molecular and Cellular Cardiology

Volumn 93, Issue , 2016, Pages 73-83

  Zeigler, Angela C ^a   Richardson, William J ^a   Holmes, Jeffrey W ^a   Saucerman, Jeffrey J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cardiac fibroblast; Computational modeling; Fibrosis; Systems biology

Indexed keywords

CARDIOVASCULAR PARAMETERS; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; EXTRACELLULAR MATRIX; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART FIBROBLAST; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SIMULATION; TISSUE REMODELLING; ANIMAL; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MODEL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; COMPUTER SIMULATION; FIBROBLAST; FIBROSIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE;

ANIMALS; ARRHYTHMIAS, CARDIAC; COMPUTER SIMULATION; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; MYOCYTES, CARDIAC; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84962588253     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.020     Document Type: Review

References (110)

1. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J. Am. Coll. Cardiol. 1989, 13:1637-1652. 10.1016/0735-1097(89)90360-4.
2. Souders C.A., Bowers S.L.K., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circ. Res. 2009, 105:1164-1176. 10.1161/CIRCRESAHA.109.209809.
3. Miragoli M., Gaudesius G., Rohr S. Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ. Res. 2006, 98:801-810. 10.1161/01.RES.0000214537.44195.a3.
4. Díaz-Araya G., Vivar R., Humeres C., Boza P., Bolivar S., Muñoz C. Cardiac fibroblasts as sentinel cells in cardiac tissue: receptors, signaling pathways and cellular functions. Pharmacol. Res. 2015, 10.1016/j.phrs.2015.07.001.
5. Shibukawa Y., Chilton E.L., Maccannell K.A., Clark R.B., Giles W.R. K+ currents activated by depolarization in cardiac fibroblasts. Biophys. J. 2005, 88:3924-3935. 10.1529/biophysj.104.054429.
6. Ma Y., Halade G.V., Zhang J., Ramirez T.A., Levin D., Voorhees A., et al. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ. Res. 2013, 112:675-688. 10.1161/CIRCRESAHA.111.300502.
7. Sun Y., Weber K.T. Infarct scar: a dynamic tissue. Cardiovasc. Res. 2000, 46:250-256. 10.1016/S0008-6363(00)00032-8.
8. Willems I.E., Havenith M.G., De Mey J.G., Daemen M.J. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol. 1994, 145:868-875.
9. Asbun J., Villarreal F.J. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 2006, 47:693-700. 10.1016/j.jacc.2005.09.050.
10. Galvão V., Miranda J.G.V. A three-dimensional multi-agent-based model for the evolution of Chagas' disease. Biosystems 2010, 100:225-230. 10.1016/j.biosystems.2010.03.007.
11. Nishtala K., Phong T.Q., Steil L., Sauter M., Salazar M.G., Kandolf R., et al. Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes. Proteomics 2011, 11:4310-4320. 10.1002/pmic.201100229.
12. Rabkin E., Aikawa M., Stone J.R., Fukumoto Y., Libby P., Schoen F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001, 104:2525-2532. 10.1161/hc4601.099489.
13. Wong T.C., Piehler K., Meier C.G., Testa S.M., Klock A.M., Aneizi A.A., et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012, 126:1206-1216. 10.1161/CIRCULATIONAHA.111.089409.
14. Moreo A., Ambrosio G., De Chiara B., Pu M., Tran T., Mauri F., et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ. Cardiovasc. Imaging 2009, 2:437-443. 10.1161/CIRCIMAGING.108.838367.
15. Krul S.P.J., Berger W.R., Smit N.W., van Amersfoorth S.C.M., Driessen A.H.G., van Boven W.J., et al. Atrial fibrosis and conduction slowing in the left atrial appendage of patients undergoing thoracoscopic surgical pulmonary vein isolation for atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2015, 8:288-295. 10.1161/CIRCEP.114.001752.
16. Trayanova N.A., Boyle P.M. Advances in modeling ventricular arrhythmias: from mechanisms to the clinic. Wiley Interdiscip. Rev. Syst. Biol. Med. 2014, 6:209-224. 10.1002/wsbm.1256.
17. Yang J.H., Saucerman J.J. Computational models reduce complexity and accelerate insight into cardiac signaling networks. Circ. Res. 2011, 108:85-97. 10.1161/CIRCRESAHA.110.223602.
18. Rohr S. Myofibroblasts in diseased hearts: new players in cardiac arrhythmias?. Heart Rhythm. 2009, 6:848-856. 10.1016/j.hrthm.2009.02.038.
19. Spach M.S., Boineau J.P. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin. Electrophysiol. 1997, 20:397-413.
20. Gaudesius G., Miragoli M., Thomas S.P., Rohr S. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ. Res. 2003, 93:421-428. 10.1161/01.RES.0000089258.40661.0C.
21. Chilton L., Ohya S., Freed D., George E., Drobic V., Shibukawa Y., et al. K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2931-H2939. 10.1152/ajpheart.01220.2004.
22. Kohl P., Kamkin A.G., Kiseleva I.S., Noble D. Mechanosensitive fibroblasts in the sino-atrial node region of rat heart: interaction with cardiomyocytes and possible role. Exp. Physiol. 1994, 79:943-956.
23. Oren R.V., Clancy C.E. Determinants of heterogeneity, excitation and conduction in the sinoatrial node: a model study. PLoS Comput. Biol. 2010, 6. 10.1371/journal.pcbi.1001041.
24. MacCannell K.A., Bazzazi H., Chilton L., Shibukawa Y., Clark R.B., Giles W.R. A mathematical model of electrotonic interactions between ventricular myocytes and fibroblasts. Biophys. J. 2007, 92:4121-4132. 10.1529/biophysj.106.101410.
25. ten Tusscher K.H.W.J., Noble D., Noble P.J., Panfilov A.V. A model for human ventricular tissue. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1573-H1589. 10.1152/ajpheart.00794.2003.
26. Jacquemet V., Henriquez C.S. Modelling cardiac fibroblasts: interactions with myocytes and their impact on impulse propagation. Europace 2007, 9(Suppl 6). 10.1093/europace/eum207.
27. Bondarenko V.E., Szigeti G.P., Bett G.C.L., Kim S.-J., Rasmusson R.L. Computer model of action potential of mouse ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1378-H1403. 10.1152/ajpheart.00185.2003.
28. Ramirez R.J., Nattel S., Courtemanche M. Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H1767-H1785.
29. Jacquemet V., Henriquez C.S. Loading effect of fibroblast-myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2040-H2052. 10.1152/ajpheart.01298.2007.
30. Sachse F.B., Moreno A.P., Abildskov J.A. Electrophysiological modeling of fibroblasts and their interaction with myocytes. Ann. Biomed. Eng. 2008, 36:41-56. 10.1007/s10439-007-9405-8.
31. Xie Y., Garfinkel A., Weiss J.N., Qu Z. Cardiac alternans induced by fibroblast-myocyte coupling: mechanistic insights from computational models. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H775-H784. 10.1152/ajpheart.00341.2009.
32. Xie Y., Garfinkel A., Camelliti P., Kohl P., Weiss J.N., Qu Z. Effects of fibroblast-myocyte coupling on cardiac conduction and vulnerability to reentry: a computational study. Heart Rhythm. 2009, 6:1641-1649. 10.1016/j.hrthm.2009.08.003.
33. Sachse F.B., Moreno A.P., Seemann G., Abildskov J.A. A model of electrical conduction in cardiac tissue including fibroblasts. Ann. Biomed. Eng. 2009, 37:874-889. 10.1007/s10439-009-9667-4.
34. Zlochiver S., Muñoz V., Vikstrom K.L., Taffet S.M., Berenfeld O., Jalife J. Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys. J. 2008, 95:4469-4480. 10.1529/biophysj.108.136473.
35. Viswanathan P.C., Shaw R.M., Rudy Y. Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation 1999, 99:2466-2474. 10.1161/01.CIR.99.18.2466.
36. Greisas A., Zlochiver S. Modulation of spiral-wave dynamics and spontaneous activity in a fibroblast/myocyte heterocellular tissue - a computational study. IEEE Trans. Biomed. Eng. 2012, 59:1398-1407. 10.1109/TBME.2012.2188291.
37. Ashihara T., Haraguchi R., Nakazawa K., Namba T., Ikeda T., Nakazawa Y., et al. The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation. Circ. Res. 2012, 110:275-284. 10.1161/CIRCRESAHA.111.255026.
38. McDowell K.S., Arevalo H.J., Maleckar M.M., Trayanova N.A. Susceptibility to arrhythmia in the infarcted heart depends on myofibroblast density. Biophys. J. 2011, 101:1307-1315. 10.1016/j.bpj.2011.08.009.
39. Kohl P., Gourdie R.G. Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue?. J. Mol. Cell. Cardiol. 2014, 70:37-46. 10.1016/j.yjmcc.2013.12.024.
40. Bogen D.K., Rabinowitz S.A., Needleman A., McMahon T.A., Abelmann W.H. An analysis of the mechanical disadvantage of myocardial infarction in the canine left ventricle. Circ. Res. 1980, 47:728-741.
41. Fomovsky G.M., Macadangdang J.R., Ailawadi G., Holmes J.W. Model-based design of mechanical therapies for myocardial infarction. J. Cardiovasc. Transl. Res. 2011, 4:82-91. 10.1007/s12265-010-9241-3.
42. Moyer C.B., Norton P.T., Ferguson J.D., Holmes J.W. Changes in global and regional mechanics due to atrial fibrillation: insights from a coupled finite-element and circulation model. Ann. Biomed. Eng. 2015, 43:1600-1613. 10.1007/s10439-015-1256-0.
43. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114:2627-2635. 10.1161/CIRCULATIONAHA.106.657270.
44. Wenk J.F., Sun K., Zhang Z., Soleimani M., Ge L., Saloner D., et al. Regional left ventricular myocardial contractility and stress in a finite element model of posterobasal myocardial infarction. J. Biomech. Eng. 2011, 133:044501. 10.1115/1.4003438.
45. Creemers E.E.J.M., Cleutjens J.P.M., Smits J.F.M., Daemen M.J.A.P. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ. Res. 2001, 89:201-210. 10.1161/hh1501.094396.
46. Lindsey M.L., Zamilpa R. Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc. Ther. 2012, 30:31-41. 10.1111/j.1755-5922.2010.00207.x.
47. Vanhoutte D., Schellings M., Pinto Y., Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc. Res. 2006, 69:604-613. 10.1016/j.cardiores.2005.10.002.
48. Wang H., Nair A., Chen C.S., Wells R.G., Shenoy V.B. Long range force transmission in fibrous matrices enabled by tension-driven alignment of fibers. Biophys. J. 2014, 107:2592-2603. (Submitted). 10.1016/j.bpj.2014.09.044.
49. Harris A.K., Stopak D., Wild P. Fibroblast traction as a mechanism for collagen morphogenesis. Nature 1981, 290:249-251.
50. Birk D.E., Trelstad R.L. Extracellular compartments in tendon morphogenesis: collagen fibril, bundle, and macroaggregate formation. J. Cell Biol. 1986, 103:231-240.
51. Trelstad R.L., Hayashi K. Tendon collagen fibrillogenesis: intracellular subassemblies and cell surface changes associated with fibril growth. Dev. Biol. 1979, 71:228-242.
52. Canty E.G., Lu Y., Meadows R.S., Shaw M.K., Holmes D.F., Kadler K.E. Coalignment of plasma membrane channels and protrusions (fibripositors) specifies the parallelism of tendon. J. Cell Biol. 2004, 165:553-563. 10.1083/jcb.200312071.
53. Nahrendorf M., Sam F.H.M. Monocyte and macrophage contributions to cardiac remodeling. J. Mol. Cell. Cardiol. 2016.
54. Richardson W.J., Clarke S.A.H.J. Modifying the mechanics of healing infarcts: better the enemy of good?. J. Mol. Cell. Cardiol. 2016.
55. Driessen N.J., Boerboom R.A., Huyghe J.M., Bouten C.V., Baaijens F.P. Computational analyses of mechanically induced collagen fiber remodeling in the aortic heart valve. J. Biomech. Eng. 2003, 125:549-557.
56. Driessen N.J.B., Bouten C.V.C., Baaijens F.P.T. Improved prediction of the collagen fiber architecture in the aortic heart valve. J. Biomech. Eng. 2005, 127:329-336.
57. Driessen N.J.B., Cox M.A.J., Bouten C.V.C., Baaijens F.P.T. Remodelling of the angular collagen fiber distribution in cardiovascular tissues. Biomech. Model. Mechanobiol. 2008, 7:93-103. 10.1007/s10237-007-0078-x.
58. Dallon J.C., Sherratt J.A., Maini P.K. Mathematical modelling of extracellular matrix dynamics using discrete cells: fiber orientation and tissue regeneration. J. Theor. Biol. 1999, 199:449-471. 10.1006/jtbi.1999.0971.
59. Dallon J., Sherratt J., Maini P., Ferguson M. Biological implications of a discrete mathematical model for collagen deposition and alignment in dermal wound repair. IMA J. Math. Appl. Med. Biol. 2000, 17:379-393.
60. Dallon JC, Sherratt JA, Maini PK. Modeling the effects of transforming growth factor-beta on extracellular matrix alignment in dermal wound repair. Wound Repair Regen. 9:278-86.
61. McDougall S., Dallon J., Sherratt J., Maini P. Fibroblast migration and collagen deposition during dermal wound healing: mathematical modelling and clinical implications. Philos. Trans. A Math Phys. Eng. Sci. 2006, 364:1385-1405. 10.1098/rsta.2006.1773.
62. Rouillard A.D., Holmes J.W. Mechanical regulation of fibroblast migration and collagen remodelling in healing myocardial infarcts. J. Physiol. 2012, 590:4585-4602. 10.1113/jphysiol.2012.229484.
63. Fomovsky G.M., Rouillard A.D., Holmes J.W. Regional mechanics determine collagen fiber structure in healing myocardial infarcts. J. Mol. Cell. Cardiol. 2012, 52:1083-1090. 10.1016/j.yjmcc.2012.02.012.
64. Fomovsky G.M., Holmes J.W. Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H221-H228. 10.1152/ajpheart.00495.2009.
65. Holmes J.W., Nuñez J.A., Covell J.W. Functional implications of myocardial scar structure. Am. J. Phys. 1997, 272:H2123-H2130.
66. Rouillard A.D., Holmes J.W. Coupled agent-based and finite-element models for predicting scar structure following myocardial infarction. Prog. Biophys. Mol. Biol. 2014, 10.1016/j.pbiomolbio.2014.06.010.
67. Reinhardt J.W., Gooch K.J. Agent-based modeling traction force mediated compaction of cell-populated collagen gels using physically realistic fibril mechanics. J. Biomech. Eng. 2014, 136:021024. 10.1115/1.4026179.
68. Checa S., Rausch M.K., Petersen A., Kuhl E., Duda G.N. The emergence of extracellular matrix mechanics and cell traction forces as important regulators of cellular self-organization. Biomech. Model. Mechanobiol. 2014, 10.1007/s10237-014-0581-9.
69. Neagu A., Mironov V., Kosztin I., Barz B., Neagu M., Moreno-Rodriguez R.A., et al. Computational modeling of epithelial-mesenchymal transformations. Biosystems 2010, 100:23-30. 10.1016/j.biosystems.2009.12.004.
70. Jin Y.-F., Han H.-C., Berger J., Dai Q., Lindsey M.L. Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling. BMC Syst. Biol. 2011, 5:60. 10.1186/1752-0509-5-60.
71. Galvão V., Miranda J.G.V., Ribeiro-dos-Santos R. Development of a two-dimensional agent-based model for chronic chagasic cardiomyopathy after stem cell transplantation. Bioinformatics 2008, 24:2051-2056. 10.1093/bioinformatics/btn362.
72. Soares M.B., Silva-Mota K.N., Lima R.S., Bellintani M.C., Pontes-de-Carvalho L., Ribeiro-dos-Santos R. Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. Am. J. Pathol. 2001, 159:703-709. 10.1016/S0002-9440(10)61741-5.
73. Soares M.B.P., Lima R.S., Rocha L.L., Takyia C.M., Pontes-de-Carvalho L., de Carvalho A.C.C., et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am. J. Pathol. 2004, 164:441-447.
74. Brown B.N., Price I.M., Toapanta F.R., DeAlmeida D.R., Wiley C.A., Ross T.M., et al. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Math. Biosci. 2011, 231:186-196. 10.1016/j.mbs.2011.03.005.
75. Voit E.O. Mesoscopic modeling as a starting point for computational analyses of cystic fibrosis as a systemic disease. Biochim. Biophys. Acta, Proteins Proteomics 1844, 2014:258-270. 10.1016/j.bbapap.2013.03.023.
76. Dutta-Moscato J., Solovyev A., Mi Q., Nishikawa T., Soto-Gutierrez A., Fox I.J., et al. A multiscale agent-based in silico model of liver fibrosis progression. Front Bioeng. Biotechnol. 2014, 2:1-10. 10.3389/fbioe.2014.00018.
77. Hao W., Rovin B.H., Friedman A. Mathematical model of renal interstitial fibrosis. Proc. Natl. Acad. Sci. 2014, 111:14193-14198. 10.1073/pnas.1413970111.
78. Schoeberl B., Eichler-Jonsson C., Gilles E.D., Müller G. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat. Biotechnol. 2002, 20:370-375. 10.1038/nbt0402-370.
79. Vempati P., Karagiannis E.D., Popel A.S. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J. Biol. Chem. 2007, 282:37585-37596. 10.1074/jbc.M611500200.
80. Shinde A.V., Frangogiannis N.G. Fibroblasts in myocardial infarction: a role in inflammation and repair. J. Mol. Cell. Cardiol. 2014, 70:74-82. 10.1016/j.yjmcc.2013.11.015.
81. Hautaniemi S., Kharait S., Iwabu A., Wells A., Lauffenburger D.A. Modeling of signal-response cascades using decision tree analysis. Bioinformatics 2005, 21:2027-2035. 10.1093/bioinformatics/bti278.
82. Kharait S., Hautaniemi S., Wu S., Iwabu A., Lauffenburger D.A., Wells A. Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility. BMC Syst. Biol. 2007, 1:9. 10.1186/1752-0509-1-9.
83. Rangamani P., Fardin M.A., Xiong Y., Lipshtat A., Rossier O., Sheetz M.P., et al. Signaling network triggers and membrane physical properties control the actin cytoskeleton-driven isotropic phase of cell spreading. Biophys. J. 2011, 100:845-857. 10.1016/j.bpj.2010.12.3732.
84. Schroer A.K., Ryzhova L.M., Merryman W.D. Network modeling approach to predict myofibroblast differentiation. Cell. Mol. Bioeng. 2014, 7:446-459. 10.1007/s12195-014-0344-9.
85. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13:952-961. 10.1038/nm1613.
86. Desai P., Yang J., Tian B., Sun H., Kalita M., Ju H., et al. Mixed-effects model of epithelial-mesenchymal transition reveals rewiring of signaling networks. Cell. Signal. 2015, 27:1413-1425. 10.1016/j.cellsig.2015.03.024.
87. Furtado M.B., Costa M.W., Pranoto E.A., Salimova E., Pinto A.R., Lam N.T., et al. Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ. Res. 2014, 114:1422-1434. 10.1161/CIRCRESAHA.114.302530.
88. Rouillard A.D., Holmes J.W. Mechanical boundary conditions bias fibroblast invasion in a collagen-fibrin wound model. Biophys. J. 2014, 106:932-943. 10.1016/j.bpj.2013.12.002.
89. Holland D.O., Krainak N.C., Saucerman J.J. Graphical approach to model reduction for nonlinear biochemical networks. PLoS One 2011, 6. 10.1371/journal.pone.0023795.
90. Driesen R.B., Nagaraju C.K., Abi-Char J., Coenen T., Lijnen P.J., Fagard R.H., et al. Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc. Res. 2014, 101:411-422. 10.1093/cvr/cvt338.
91. Bazil J.N., Stamm K.D., Li X., Thiagarajan R., Nelson T.J., Tomita-Mitchell A., et al. The inferred cardiogenic gene regulatory network in the mammalian heart. PLoS One 2014, 9. 10.1371/journal.pone.0100842.
92. Nim H.T., Boyd S.E., Rosenthal N.A. Systems approaches in integrative cardiac biology: illustrations from cardiac heterocellular signalling studies. Prog. Biophys. Mol. Biol. 2015, 117:69-77. 10.1016/j.pbiomolbio.2014.11.006.
93. Jensen K.J., Garmaroudi F.S., Zhang J., Lin J., Boroomand S., Zhang M., et al. An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection. Cell Host Microbe 2013, 13:67-76. 10.1016/j.chom.2012.11.009.
94. Kupfer P., Huber R., Weber M., Vlaic S., Häupl T., Koczan D., et al. Novel application of multi-stimuli network inference to synovial fibroblasts of rheumatoid arthritis patients. BMC Med. Genet. 2014, 7:40. 10.1186/1755-8794-7-40.
95. Weber K.T., Sun Y., Bhattacharya S.K., Ahokas R.A., Gerling I.C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 2013, 10:15-26. 10.1038/nrcardio.2012.158.
96. Walpole J., Papin J.A., Peirce S.M. Multiscale computational models of complex biological systems. Annu. Rev. Biomed. Eng. 2013, 15:137-154. 10.1146/annurev-bioeng-071811-150104.
97. Bajikar S.S., Janes K.A. Multiscale models of cell signaling. Ann. Biomed. Eng. 2012, 40:2319-2327. 10.1007/s10439-012-0560-1.
98. Fedosov D.A., Noguchi H., Gompper G. Multiscale modeling of blood flow: from single cells to blood rheology. Biomech. Model. Mechanobiol. 2014, 13:239-258. 10.1007/s10237-013-0497-9.
99. Vermolen F., Gefen A. Wound Healing: Multi-Scale Modeling. Multiscale Comput. Model. Biomech. Biomed. Eng. 2013, 321-345. Springer Berlin Heidelberg, Berlin, Heidelberg. A. Gefen (Ed.).
100. Hayenga H., Thorne B., Yen P., Papin J., Peirce S.M., Humphrey J.D. Multiscale Computational Modeling in Vascular Biology: From Molecular Mechanisms to Tissue-Level Structure and Function. Multiscale Comput. Model. Biomech. Biomed. Eng. 2013, 209-240. Springer Berlin Heidelberg, Berlin, Heidelberg. A. Gefen (Ed.).
101. Weinberg E.J., Shahmirzadi D., Mofrad M.R.K. On the multiscale modeling of heart valve biomechanics in health and disease. Biomech. Model. Mechanobiol. 2010, 9:373-387. 10.1007/s10237-009-0181-2.
102. Hunter P.J., Li W.W., McCulloch A.D., Noble D. Multiscale modeling: physiome project standards, tools, and databases. Computer (Long Beach Calif) 2006, 39:48-54. 10.1109/MC.2006.392.
103. Campbell S.G., McCulloch A.D. Multi-scale computational models of familial hypertrophic cardiomyopathy: genotype to phenotype. J. R. Soc. Interface 2011, 8:1550-1561. 10.1098/rsif.2011.0184.
104. Czubryt M.P., Safi H.A.N.R. Gaining myocytes or losing fibroblasts: challenges in cardiac fibroblast reprogramming for infarct repair. J. Mol. Cell. Cardiol. 2016.
105. Ryall K.A., Holland D.O., Delaney K.A., Kraeutler M.J., Parker A.J., Saucerman J.J. Network reconstruction and systems analysis of cardiac myocyte hypertrophy signaling. J. Biol. Chem. 2012, 287:42259-42268. 10.1074/jbc.M112.382937.
106. Ryall K.A., Bezzerides V.J., Rosenzweig A., Saucerman J.J. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation. J. Mol. Cell. Cardiol. 2014, 72:74-84. 10.1016/j.yjmcc.2014.02.013.
107. Yang J.H., Polanowska-Grabowska R.K., Smith J.S., Shields C.W., Saucerman J.J. PKA catalytic subunit compartmentation regulates contractile and hypertrophic responses to β-adrenergic signaling. J. Mol. Cell. Cardiol. 2014, 66:83-93. 10.1016/j.yjmcc.2013.11.001.
108. Greenwald E.C., Redden J.M., Dodge-Kafka K.L., Saucerman J.J. Scaffold state switching amplifies, accelerates, and insulates protein kinase c signaling. J. Biol. Chem. 2014, 289:2353-2360. 10.1074/jbc.M113.497941.
109. Clancy C.E., Rudy Y. Na+ channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 2002, 105:1208-1213. 10.1161/hc1002.105183.
110. Visser S.A.G., de Alwis D.P., Kerbusch T., Stone J.A., Allerheiligen S.R.B. Implementation of quantitative and systems pharmacology in large pharma. CPT Pharmacometrics Syst. Pharmacol. 2014, 3. 10.1038/psp.2014.40.